• Skills People And Talent

James Keeling, new Chief Financial Officer at Stevenage Bioscience Catalyst

Stevenage Bioscience Catalyst (SBC), a leading location for development and commercialisation of cutting-edge therapeutics, is pleased to announce that James Keeling has been appointed as Chief Financial Officer (CFO).

Dr. Philip Beer joins CCG.ai

Dr. Philip Beer joins Cambridge Cancer Genomics as Head of Translational Medicine

Global Head of Neuroscience Discovery marks the official launch of The Biosphere

On Thursday 4 July Dr. Fiona Marshall, Global Head of Neuroscience Discovery, MSD visited Newcastle to mark the official launch of The Biosphere.

Cancer vaccine firm Oxford Vacmedix announces collaboration and Innovate UK grant

CHAIN Biotechnology and University of Oxford have been awarded grant funding to develop live biotherapeutics that support oral delivery of Oxford Vacmedix’s immunotherapy cancer vaccines.

Theolytics Limited comes out of stealth mode with Dr Ken Powell announced as Chair of the Board

We're thrilled to announce the appointment of Dr Ken Powell as Chair to the Board of Directors for Theolytics. Ken brings extensive virology and commercial expertise, including from founding roles at Arrow Therapeutics and Reviral.

Medherant positions itself for the next stage of its development with the appointment of a new CEO

Medherant Limited (“Medherant”), the clinical-stage company developing innovative products for pain and CNS diseases using a unique transdermal delivery technology, TEPI Patch®, has appointed John Burt as Chief Executive Officer, effective 24 June 2019. Nigel Davis, the current CEO, will remain with the Company as Chief Business Officer.

Cobra Biologics and Symbiosis Complete £4.8m Viral Vector Supply Chain Collaboration

Developing world-leading capabilities in drug substance and drug product viral vector production for gene and immunotherapy.

Guest blog | Sean Morgan-Jones | UK Biotech PLC is Totally Smashing It...

‘The UK is leading a two speed Europe’ (McKinsey & Company, Biotech in Europe: Scaling Innovation May 20, 2019). One of the key findings and contrary to the received wisdom, is that the UK is totally smashing it on all measures as a Biotech hot spot according to research presented at BioEquity Europe in Barcelona by McKinsey & Company looking at where's hot and where's not. Of the 1,000 European Biotechs established since 2012 the UK is leading by a country mile and represents 35% of all new Biotechs and according to the report and is leading a two speed Europe (with Germany, France and Spain in relative decline). 

CEO Update | Tuesday 11 June 2019

Many congratulations to BIA Chair, Dr Jane Osbourn who has been awarded an OBE in the Queen’s birthday honours announced at the weekend. Jane is a true pioneer in our sector, who not only has pioneered world-class research and contributed to blockbuster discoveries but is a passionate advocate for the UK life sciences sector. For me, Jane’s greatest qualities are her abilities to communicate and lead, she has and always will be a trailblazer in our sector and I’m delighted that she has received this award. In Westminster the Conservative leadership contest to replace Theresa May is underway and we have produced a life sciences focused guide to the runners and riders which is available here.


Instinctif Partners’ Corporate and Capital Markets practice has made two Managing Partner promotions in its UK business.